Lift Therapeutics
Develops neutrophil-based cell immunotherapies for patients with hard-to-treat solid cancers
Highlights
- New on EvolcAdded 2026-11-08
About Lift Therapeutics
Lift Therapeutics develops allogeneic Immuno-Modulatory Alpha Neutrophils (IMANs), off-the-shelf cell therapies intended to kill tumor cells and stimulate anti-tumor immunity. Its pipeline targets multiple solid cancers; an upcoming Phase 1 study is planned for patients with advanced cervical, head and neck cancers.
The company is registered in London and was founded in 2014. It seeks immunologists and cell biologists experienced in stem cell expansion, differentiation and cell-based assays, as well as candidates in finance, operations and business development.
Product: Allogeneic neutrophil-lineage cell therapies for solid cancers.
Jobs at Lift Therapeutics
More biotech & pharma companies
Lightcast Discovery
Single-cell functional screening platform for antibody and drug discovery teams in biotech and pharma researchLiminal Biosciences
Develops small-molecule therapeutics for metabolic, inflammatory and fibrotic diseases through GPCR pathwaysNew on EvolcLindus Health
Clinical development of in-licensed drug assets for biotech and pharma partners, run on an AI clinical trial platformNew on EvolcRemote-friendlyLinepharma International
Develops and commercializes medication-abortion and reproductive-health medicinesNew on EvolcLink Biologics
Develops TSG-6-based protein therapeutics for inflammatory and degenerative diseasesNew on EvolcLowry Pharma
Commercialises hospital medicines in the UK for pharma manufacturers, covering registration, market access, sales and NHS logisticsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.